malondialdehyde has been researched along with cepharanthine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagiwara, S; Hasegawa, A; Koga, H; Kudo, K; Kusaka, J; Noguchi, T | 1 |
| Chou, WC; Huang, CJ; Kao, MC; Sheu, JR; Yang, CH | 1 |
2 other study(ies) available for malondialdehyde and cepharanthine
| Article | Year |
|---|---|
Cepharanthine improves renal ischemia-reperfusion injury in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylisoquinolines; Disease Models, Animal; Kidney; Kidney Diseases; Male; Malondialdehyde; Microscopy, Electron, Transmission; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury | 2011 |
Cepharanthine mitigates lung injury in lower limb ischemia-reperfusion.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylisoquinolines; Blood Gas Analysis; Bronchoalveolar Lavage Fluid; Cyclooxygenase 2; Drug Evaluation, Preclinical; Heme Oxygenase-1; I-kappa B Proteins; Lung; Male; Malondialdehyde; Nitric Oxide; Phytotherapy; Plant Extracts; Random Allocation; Rats, Sprague-Dawley; Reperfusion Injury; Stephania | 2015 |